sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
¼ÒÍöú·Û´ÌÌìÉúÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ¼ÒÍöú·Û´ÌÌìÉúÄ£×Ó

ǰÑÔ

Ѱ³£×ù´¯ÊÇȬ´¯(acne)µä·¶ÌåÏÖ £¬ÓÉ4¸ö»ù±¾·¢²¡»·½Ú×é³É £¬¼´ðî´¯±ûËá¸Ë¾úºÍÓÅÊÆ»¯Å§¾úѬȾ¡¢Ã«ÄÒÆ¤Ö¬ÏÙµ¼¹Ü½Ç»¯Òì³£ºÍ·Û´ÌÌìÉú¡¢ÐÛ¼¤ËØºÍÆ¤Ö¬ÏÙÉøÍ¸Òì³£ºÍ¾Ö²¿Ñ×Ö¢·´Ó¦¡£ÏÖÔÚ £¬»¹²»¿É½¨Éè°üÀ¨ÉÏÊö4¸ö²¡Àí»·½ÚµÄ¶¯Îï¼²²¡Ä£×Ó £¬µ«¿É»®·ÖÓÕµ¼¼²²¡»ù±¾²¡Àí»·½ÚÖ®Ò»µÄ·Û´ÌÌìÉú¼°Ê¹ÓÃÕý³£¶¯ÎïÉúÎïÑ§ÌØÕ÷µÄ½ð»ÆµØÊóв²¿Æ¤Ö¬ÏÙÉ«ËØ°ß½¨ÉèÕûÌåÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¼ÒÍÃ

¡¾ÔìÄ £»úÖÆ¡¿£º

·Û´ÌÊÇëÄÒÆ¤Ö¬ÏÙµ¼¹ÜÉÏÆ¤Ï¸°û½Ç»¯Ì«¹ýºÍϸ°û¼äð¤ºÏÔöÇ¿¡¢Î¢ÉúÎïѬȾ¡¢µ¼¹Ü±ÚµÄÑ×Ö¢ËðÉ˼°Æ¤Ö¬¡¢Æ¤Ð¼ÍÑÂäÎïµÈ×ÛºÏÒòËØÌìÉú¡£ÊµÑéÓÕµ¼µÄ¼ÒÍöú·Û´ÌÄ£×Ó £¬¾­³¬Î¢½á¹¹ÆÊÎö £¬Æä²¡Àí»úÖÆÎªÃ«ÄÒ©¶·²¿ÉÏÆ¤½Ç»¯Ì«¹ý¡¢½ÇÖÊϸ°ûÍÑÂäÑÓ³Ù¡¢ÐÎ³É·Û´Ì £¬²¢ÒýÆðëÄÒ¿ÚÀ©ÕÅ¡¢ÕæÆ¤Ñ×Ö¢¡£ÓëÈ˵ķ۴ÌÐγɻúÖÆ²¿·ÖÏàËÆ¡£

¡¾Ä£×ÓÌØµã¡¿£º

¶ÔÐÂÎ÷À¼¼ÒÍÃÁ½¶úÍâÔµ¸¹²à4cm×2cmÃæ»ý»®·ÖÍ¿50£¥ÓÍËáҺ״ʯÀ¯ £¬ÌìÌì1´Î £¬¹²14Ìì¡£×éÖ¯²¡ÀíÇÐÆ¬ÊÓ²ìëÄÒ¿ÚÀ©ÕÅˮƽ¡¢½Ç˨¾Þϸ¼°±íƤ½Ç»¯Ë®Æ½¡¢ÕæÆ¤Ñ×֢ˮƽ £¬×÷¶¨ÐÔ¼°°ë¶¨Á¿ÅжÏ¡£ÈôÊÓ²ìÒ©ÎïµÄÁÆÐ§ £¬¿ÉÔÚ×ó¶úÓÕµ¼ÇøÃ¿´ÎÍ¿ÓÕµ¼¼Á1Сʱ £¬ÔÙÍ¿ÊÜÊÔÒ© £¬Ò»Á¬14Ìì £¬²¢ÒÔÓÒ¶úÍ¿»ùÖÊ×÷±ÈÕÕ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

¸ÃÄ£×Ó·Û´ÌÐγɻúÖÆÖÐûÓÐѬȾ¡¢Ñ×Ö¢¼°Æ¤Ö¬ÏÙÉøÍ¸Òì³ £»úÖÆ¼ÓÈë £¬½öΪÉÏÆ¤½Ç»¯Ì«¹ý¡¢½ÇÖÊÕ³Á¬×ª±äΪÖ÷ £¬µ«¾Ý¹â¾µ¼°µç¾µ²¡ÀíÖ¸±êËù¼ûÒÔ¼°¿¹·Û´ÌҩάAËá×÷ÓõÄҩЧ £¬ÓëÁÙ´²·Û´ÌÐγɼ°·Û´ÌÏûÈÚÀú³Ì½ÏÎǺÏ¡£

 

²Î¿¼ÎÄÏ×£º

1.Pewig G. Skin Models: Models Lo study follicular diseases. Heidelberg:Springer Verlag, 1986

2.Weissmann A, Bowden J,Frank 8. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ. Arch Dermatol, 1985, 121 (1):57-62

3.Gomez EC. Models in Dermatology. Basel: Karger, 1985

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ƥ·ô¹Ç÷À¼¡ÏµÍ³Ä£×Ó > ¼ÒÍöú·Û´ÌÌìÉúÄ£×Ó
¼ÒÍöú·Û´ÌÌìÉúÄ£×Ó

ǰÑÔ

Ѱ³£×ù´¯ÊÇȬ´¯(acne)µä·¶ÌåÏÖ £¬ÓÉ4¸ö»ù±¾·¢²¡»·½Ú×é³É £¬¼´ðî´¯±ûËá¸Ë¾úºÍÓÅÊÆ»¯Å§¾úѬȾ¡¢Ã«ÄÒÆ¤Ö¬ÏÙµ¼¹Ü½Ç»¯Òì³£ºÍ·Û´ÌÌìÉú¡¢ÐÛ¼¤ËØºÍÆ¤Ö¬ÏÙÉøÍ¸Òì³£ºÍ¾Ö²¿Ñ×Ö¢·´Ó¦¡£ÏÖÔÚ £¬»¹²»¿É½¨Éè°üÀ¨ÉÏÊö4¸ö²¡Àí»·½ÚµÄ¶¯Îï¼²²¡Ä£×Ó £¬µ«¿É»®·ÖÓÕµ¼¼²²¡»ù±¾²¡Àí»·½ÚÖ®Ò»µÄ·Û´ÌÌìÉú¼°Ê¹ÓÃÕý³£¶¯ÎïÉúÎïÑ§ÌØÕ÷µÄ½ð»ÆµØÊóв²¿Æ¤Ö¬ÏÙÉ«ËØ°ß½¨ÉèÕûÌåÄ£×Ó¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î¼ÒÍÃ

¡¾ÔìÄ £»úÖÆ¡¿£º

·Û´ÌÊÇëÄÒÆ¤Ö¬ÏÙµ¼¹ÜÉÏÆ¤Ï¸°û½Ç»¯Ì«¹ýºÍϸ°û¼äð¤ºÏÔöÇ¿¡¢Î¢ÉúÎïѬȾ¡¢µ¼¹Ü±ÚµÄÑ×Ö¢ËðÉ˼°Æ¤Ö¬¡¢Æ¤Ð¼ÍÑÂäÎïµÈ×ÛºÏÒòËØÌìÉú¡£ÊµÑéÓÕµ¼µÄ¼ÒÍöú·Û´ÌÄ£×Ó £¬¾­³¬Î¢½á¹¹ÆÊÎö £¬Æä²¡Àí»úÖÆÎªÃ«ÄÒ©¶·²¿ÉÏÆ¤½Ç»¯Ì«¹ý¡¢½ÇÖÊϸ°ûÍÑÂäÑÓ³Ù¡¢ÐÎ³É·Û´Ì £¬²¢ÒýÆðëÄÒ¿ÚÀ©ÕÅ¡¢ÕæÆ¤Ñ×Ö¢¡£ÓëÈ˵ķ۴ÌÐγɻúÖÆ²¿·ÖÏàËÆ¡£

¡¾Ä£×ÓÌØµã¡¿£º

¶ÔÐÂÎ÷À¼¼ÒÍÃÁ½¶úÍâÔµ¸¹²à4cm×2cmÃæ»ý»®·ÖÍ¿50£¥ÓÍËáҺ״ʯÀ¯ £¬ÌìÌì1´Î £¬¹²14Ìì¡£×éÖ¯²¡ÀíÇÐÆ¬ÊÓ²ìëÄÒ¿ÚÀ©ÕÅˮƽ¡¢½Ç˨¾Þϸ¼°±íƤ½Ç»¯Ë®Æ½¡¢ÕæÆ¤Ñ×֢ˮƽ £¬×÷¶¨ÐÔ¼°°ë¶¨Á¿ÅжÏ¡£ÈôÊÓ²ìÒ©ÎïµÄÁÆÐ§ £¬¿ÉÔÚ×ó¶úÓÕµ¼ÇøÃ¿´ÎÍ¿ÓÕµ¼¼Á1Сʱ £¬ÔÙÍ¿ÊÜÊÔÒ© £¬Ò»Á¬14Ìì £¬²¢ÒÔÓÒ¶úÍ¿»ùÖÊ×÷±ÈÕÕ¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

¸ÃÄ£×Ó·Û´ÌÐγɻúÖÆÖÐûÓÐѬȾ¡¢Ñ×Ö¢¼°Æ¤Ö¬ÏÙÉøÍ¸Òì³ £»úÖÆ¼ÓÈë £¬½öΪÉÏÆ¤½Ç»¯Ì«¹ý¡¢½ÇÖÊÕ³Á¬×ª±äΪÖ÷ £¬µ«¾Ý¹â¾µ¼°µç¾µ²¡ÀíÖ¸±êËù¼ûÒÔ¼°¿¹·Û´ÌҩάAËá×÷ÓõÄҩЧ £¬ÓëÁÙ´²·Û´ÌÐγɼ°·Û´ÌÏûÈÚÀú³Ì½ÏÎǺÏ¡£

 

²Î¿¼ÎÄÏ×£º

1.Pewig G. Skin Models: Models Lo study follicular diseases. Heidelberg:Springer Verlag, 1986

2.Weissmann A, Bowden J,Frank 8. Antiandrogenic effects of topically applied spironolactone on the hamster flank organ. Arch Dermatol, 1985, 121 (1):57-62

3.Gomez EC. Models in Dermatology. Basel: Karger, 1985

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿